Rabia Ozden

Rabia Ozden

Geen lopende functies
58 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Rabia Gurses Ozden worked as Executive Medical Director-Ophthalmology at Quark Pharmaceuticals, Inc. from 2011 to 2014.
The role of Vice President & Head-Clinical Ophthalmology was held at GSK Plc.
From 2015 to 2018, the position of Vice President-Clinical Research & Development was at Beacon Therapeutics (USA), Inc. Served as Assistant Professor at New York Medical College.
In 2019, the role of Chief Medical Officer was at Nightstar Therapeutics Ltd. From 2019 to 2021, Chief Development Officer was at Akouos, Inc. Chief Medical Officer roles were held at Ocular Therapeutix, Inc. from 2022 to 2024 and at Adverum Biotechnologies, Inc. from 2024 to 2025.
Education includes a doctorate degree from Hacettepe University.

Eerdere bekende functies van Rabia Ozden

BedrijvenFunctieEinde
ADVERUM BIOTECHNOLOGIES, INC. Hoofd Techniek/Wetenschap/O&O 09-12-2025
OCULAR THERAPEUTIX, INC. Hoofd Techniek/Wetenschap/O&O 20-05-2024
AKOUOS Corporate Officer/Principal 01-01-2021
NIGHTSTAR THERAPEUTICS PLC Hoofd Techniek/Wetenschap/O&O 01-12-2019
APPLIED GENETIC TECHNOLOGIES CORPORATION Hoofd Techniek/Wetenschap/O&O 01-03-2018
Ervaring van Rabia Ozden in detail bekijken

Opleiding van Rabia Ozden

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

64

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Rabia Ozden
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU